Lorna Warwick, BA, Lymphoma Coalition, Toronto, Canada, emphasizes the importance of improving the quality of life (QoL) of patients treated with CAR-T therapy, highlighting some of the unmet needs in this space, including dealing with fatigue, improving communication with patients, providing more and better supportive care to patients dealing with anxiety and depression, and reducing barriers in access to care. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.